Urinary Metabolomics-Driven Discovery of Metabolic Markers and Molecular Subtyping in Liver Cancer
Suberic acid, 2'-O-methylcytidine, and 3'-Sialyllactose hold promise as metabolic biomarkers for hepatitis B-related liver cancer. Understanding the diversity of the human liver cancer gene expression profile from a metabolomic perspective has potential applications for developing novel clinical treatment strategies.
Authors
- Hongsheng Lin (ORCID: https://orcid.org/0000-0003-0314-095X)
- Fangling Shu
- Minpeng Li
- Yexing Zhang
- Hiu Lam Athena Wu (ORCID: https://orcid.org/0009-0009-4357-7014)
- Fuli Long (ORCID: https://orcid.org/0000-0003-1196-2697)
- Yunyong Wang
- Rongzhen Zhang (ORCID: https://orcid.org/0000-0003-2243-665X)
- Mingfen Li (ORCID: https://orcid.org/0000-0002-1821-4723)
- Xiaoling Zhou (ORCID: https://orcid.org/0000-0002-5517-808X)
Institutions
- The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine (CN)
- Guangxi University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Bioscience-Landmark
- Published
- 2025-10-31
- DOI
- https://doi.org/10.31083/fbl45438
- Citations
- 1
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.81